EIKONOKLASTES THERAPEUTICS
Eikonoklastes is advancing a new generation of tissue factor (TF) immunotherapies – therapeutics designed to target the cell surface receptor now known to be prevalent on key components of the tumor microenvironment. It has recently been discovered that certain pathological cells – but not healthy cells – including cancers with high unmet need and high mortality such as triple-negative breast cancer, ovarian cancer, metastatic melanoma, and a broad range of other solid tumors, express tissue factor on the surface of their cell membranes. Several other non-cancerous indications such as endometriosis also highly and selectively express tissue factor.
EIKONOKLASTES THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Life Science
Founded:
2019-01-01
Address:
Cincinnati, Ohio, United States
Country:
United States
Website Url:
http://www.eikonoklastes.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5.98 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Umoja Biopharma
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.
Current Employees Featured
Founder
Investors List
Rev1 Ventures
Rev1 Ventures investment in Series A - Eikonoklastes Therapeutics
JobsOhio
JobsOhio investment in Series A - Eikonoklastes Therapeutics
Elk Capital Ventures
Elk Capital Ventures investment in Series A - Eikonoklastes Therapeutics
CincyTech
CincyTech investment in Series A - Eikonoklastes Therapeutics
CincyTech
CincyTech investment in Seed Round - Eikonoklastes Therapeutics
Official Site Inspections
http://www.eikonoklastes.com
- Host name: 4.139.71.34.bc.googleusercontent.com
- IP address: 34.71.139.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Eikonoklastes Therapeutics"
eikonoklastes.com Reviews: Is this site a scam or legit?
Is eikonoklastes.com legit or a scam? Read reviews, company details, technical analysis, and more to help you decide if this site is trustworthy or fraudulent.See details»
Home - Eikonoklastes
Eikonoklastes Therapeutics, a preclinical biotech company developing treatments for today’s most challenging diseases, and Forge Biologics, a gene therapy-focused contract development and …See details»
Eikonoklastes.com Review: Legit or Scam [Medium Secure Website]
Apr 10, 2024 eikonoklastes.com emphasizes that medium-safe health practices play an important role in protecting people's health and safety. Such applications enable people to find …See details»
Eikonoklastes Therapeutics, Inc. - LinkedIn
Eikonoklastes Therapeutics is an early stage biopharmaceutical company focused on rapidly advancing innovative medicines for numerous areas of significant unmet clinical need, starting …See details»
Eikonoklastes : in answer to a book intitl'd Eikon …
Eikonoklastes : in answer to a book intitl'd Eikon basilike : the portrature of his Sacred Majesty in his solitudes and sufferings / the author I [ohn]. M [ilton] by Milton, John, 1608-1674; Simons, Matthew, -1654, printer; Bliss, William …See details»
Eikonoklastes - 2025 Company Profile & Team - Tracxn
Jun 14, 2025 Eikonoklastes is a series B company based in Columbus (United States), founded in 2019 by Samuel Lee and Zhiwei Hu. It operates as a Developer of tissue factor targeting …See details»
Eikonoklastes | Rev1 Ventures
Company Profile Rapidly developing disruptive treatments for today’s most challenging diseases.See details»
The Significance of Satan: Eikonoklastes as a Guide to Reading the ...
May 9, 2012 A close reading of Eikonoklastes enables an understanding of how Milton persuades his readers by integrating political references and biblical scripture to achieve his …See details»
Eikonoklastes Facts for Kids
Eikonoklastes is a book written by John Milton. It was published in October 1649. The book's name comes from Greek words and means "icon breaker." It was written to explain and defend why Charles I was executed on January 30, …See details»
Eikonoklastes Closes Oversubscribed Series A Financing, Helping …
Jun 28, 2021 Eikonoklastes Therapeutics was founded and is led by a management team with longstanding experience of successful drug development. Working with The Ohio State …See details»
EIKONOKLASTES THERAPEUTICS, INC. - Executive Bio, Top …
Eikonoklastes Therapeutics is developing a pipeline of disruptive new therapies that we can rapidly and relatively inexpensively advance from preclinical stage to clinical proof-of-concept …See details»
Eikonoklastes. In answer to a book intitled, Eikon Basilike, the ...
Eikonoklastes. In answer to a book intitled, Eikon Basilike, the portraiture of his sacred Majesty in his solitudes and sufferings. By John Milton. Now first...See details»
Eikonoklastes - Students | Britannica Kids | Homework Help
English poet John Milton’s Eikonoklastes (Image Breaker) was written in defense of the execution of King Charles I by England’s Puritan-controlled Parliament in 1649. It was…See details»
Eikonoklastes Therapeutics and Forge Biologics Announce Viral …
Nov 29, 2022 CINCINNATI and COLUMBUS, Ohio – November 29, 2022 – Eikonoklastes Therapeutics, a preclinical biotech company developing treatments for today’s most …See details»
Eikonoklastes Therapeutics - Contacts, Employees, Board Members ...
Eikonoklastes Therapeutics has 3 current employee profiles, including Chief Scientific Officer and Chief Medical Officer Mark Dato. Eikonoklastes Therapeutics has 1 board member or advisor, …See details»
Eikonoklastes Therapeutics: Revenue, Worth, Valuation
About Eikonoklastes Therapeutics Eikonoklastes Therapeutics is a Biotech related company with 10 employees an estimated revenue of $775K, and. It has 10 competitors including Dermavant …See details»
John Milton – Eikonoklastes (1649)
JOHN MILTON John Milton - Eikonoklastes (1649) Following the end of the English Civil War, the country was rattled by the destruction of the monarchy and the execution of a king. Many …See details»
eikonoklastes - Students | Britannica Kids | Homework Help
John Milton wrote <i>Eikonoklastes</i> in defense of the execution of King Charles I by England's Puritan-controled Parliament in 1649.See details»
Eikonoklastes: Introduction - Dartmouth
Introduction Composing Eikonoklastes was one of the first assignments John Milton undertook as Secretary for Foreign Languages to Oliver Cromwell's Council of State. He published The …See details»
Eikonoklastes, 1649 : John Geraghty : Free Download, Borrow, and ...
Aug 6, 2013 Eikonoklastes, 1649 by John Geraghty Topics Eikonoklastes, John Milton, 1649, English Civil War, regicide Collection opensource Item Size 163.2M John Milton Eikonoklastes …See details»